ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
+26.93%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$125M
AUM Growth
+$125M
(+26%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-6.73%
Top 10 Holdings %
Top 10 Hldgs %
97.16%
Holding
17
New
2
Increased
3
Reduced
4
Closed
3
Top Buys
| 1 |
ProQR Therapeutics
PRQR
|
$6.75M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$2.45M |
| 3 |
Synlogic
SYBX
|
$477K |
| 4 |
Spero Therapeutics
SPRO
|
$287K |
| 5 |
Merus
MRUS
|
$157K |
Top Sells
| 1 |
CytomX Therapeutics
CTMX
|
$4.55M |
| 2 |
argenx
ARGX
|
$4.4M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$3.47M |
| 4 |
uniQure
QURE
|
$2.63M |
| 5 |
Galapagos
GLPG
|
$1.66M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merus
MRUS
$4.98B
| $22M | 9.75% |
1,491,497
+10,642
| +0.7% | +$157K |
|
|
2
uniQure
QURE
$896M
| $21.7M | 9.63% |
364,596
-44,133
| -11% | -$2.63M |
|
3
Arrowhead Research
ARWR
$3.05B
| $18M | 7.98% |
982,455
-82,473
| -8% | -$1.51M |
|
|
4
Spero Therapeutics
SPRO
$116M
| $13.5M | 5.98% |
1,054,356
+22,409
| +2% | +$287K |
|
5
Fate Therapeutics
FATE
$120M
| $12.2M | 5.42% |
697,096
| – | – |
|
|
6
Synlogic
SYBX
$17M
| $10.6M | 4.69% |
1,397,016
+62,837
| +5% | +$477K |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $9.67M | 4.28% |
951,527
| – | – |
|
|
8
ProQR Therapeutics
PRQR
$237M
| $6.75M | 2.99% |
+486,698
| New | +$6.75M |
|
|
PVLA
9
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $4.06M | 1.8% |
1,210,837
| – | – |
|
|
10
Galapagos
GLPG
$2.07B
| $2.57M | 1.14% |
21,840
-14,080
| -39% | -$1.66M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $2.45M | 1.08% |
+30,618
| New | +$2.45M |
|
|
12
CytomX Therapeutics
CTMX
$336M
| $1.09M | 0.48% |
101,767
-422,996
| -81% | -$4.55M |
|
|
13
argenx
ARGX
$43.6B
| – | – |
-45,806
| Closed | -$4.4M |
|
14
iShares Biotechnology ETF
IBB
$5.6B
| – | – |
0
| – | – |
|
15
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
MOR
16
DELISTED
MorphoSys AG American Depositary Shares
MOR
| – | – |
-11,787
| Closed | -$298K |
|
|
LOXO
17
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-24,750
| Closed | -$3.47M |
|